{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:20Z","timestamp":1790336960528,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.celrep.2020.108407","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T21:35:46Z","timestamp":1605735346000},"page":"108407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome"],"prefix":"10.1016","volume":"33","author":[{"given":"Kathryn D.","family":"Tuttle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Minter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0417-1400","authenticated-orcid":false,"given":"David J.","family":"Orlicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Andrysik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-2962","authenticated-orcid":false,"given":"Matthew A.","family":"Burchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.J.","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-9283","authenticated-orcid":false,"given":"Colin","family":"Sempeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-6339","authenticated-orcid":false,"given":"Keith","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-831X","authenticated-orcid":false,"given":"Ross","family":"Granrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin M.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2020.108407_bib1","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1542\/peds.2011-1262","article-title":"Lipid profiles of children with Down syndrome compared with their siblings","volume":"129","author":"Adelekan","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.celrep.2020.108407_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celrep.2020.108407_bib3","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T\u00a0cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2020.108407_bib4","doi-asserted-by":"crossref","first-page":"dmm031013","DOI":"10.1242\/dmm.031013","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of Down syndrome","volume":"11","author":"Aziz","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.celrep.2020.108407_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2019.12.039","article-title":"Early Hyperbilirubinemia in Neonates with Down Syndrome","volume":"219","author":"Bahr","year":"2020","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.celrep.2020.108407_bib6","doi-asserted-by":"crossref","first-page":"e20180225","DOI":"10.1542\/peds.2018-0225","article-title":"Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis","volume":"142","author":"Beckhaus","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.celrep.2020.108407_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: Abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.celrep.2020.108407_bib8","first-page":"191","article-title":"Thyroid dysfunction in patients with Down syndrome","volume":"48","author":"Chen","year":"2007","journal-title":"Acta Paediatr. Taiwan."},{"key":"10.1016\/j.celrep.2020.108407_bib9","article-title":"COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults","author":"Clift","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.celrep.2020.108407_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.celrep.2020.108407_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s12072-013-9477-5","article-title":"Lean NASH: distinctiveness and clinical implication","volume":"7","author":"Das","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.celrep.2020.108407_bib13","article-title":"Are patients with Down syndrome vulnerable to life-threatening COVID-19?","author":"De Cauwer","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.celrep.2020.108407_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/011542650602100168","article-title":"The origins of cachexia in acute and chronic inflammatory diseases","volume":"21","author":"Delano","year":"2006","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.celrep.2020.108407_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0960-7404(94)90027-2","article-title":"Tumor necrosis factor and cachexia: a current perspective","volume":"3","author":"Espat","year":"1994","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.celrep.2020.108407_bib16","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.1016\/j.xcrm.2020.100019","article-title":"Immune mechanisms for increased risk of severe COVID-19 in Down syndrome","volume":"1","author":"Espinosa","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib17","doi-asserted-by":"crossref","first-page":"e000890","DOI":"10.1136\/rmdopen-2018-000890","article-title":"Arthropathy of Down syndrome: an under-diagnosed inflammatory joint disease that warrants a name change","volume":"5","author":"Foley","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.celrep.2020.108407_bib18","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.108407_bib19","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.174.6.1425","article-title":"Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression","volume":"174","author":"Fung-Leung","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate pro-inflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.celrep.2020.108407_bib21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/adc.2003.046219","article-title":"Cancers and immune related diseases associated with Down\u2019s syndrome: a record linkage study","volume":"89","author":"Goldacre","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.celrep.2020.108407_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","article-title":"Mouse models of Down syndrome: gene content and consequences","volume":"27","author":"Gupta","year":"2016","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.celrep.2020.108407_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: Common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.celrep.2020.108407_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2020.108407_bib25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.celrep.2020.108407_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2020.108407_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.108407_bib29","doi-asserted-by":"crossref","first-page":"e20196","DOI":"10.7554\/eLife.20196","article-title":"Signaling a link between interferon and the traits of Down syndrome","volume":"5","author":"Kirsammer","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2020.108407_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2020.108407_bib31","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1172\/JCI94427","article-title":"Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice","volume":"128","author":"Lanaspa","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2020.108407_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/hmg\/ddm086","article-title":"Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities","volume":"16","author":"Li","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2020.108407_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcl.2014.09.009","article-title":"Down syndrome preleukemia and leukemia","volume":"62","author":"Maloney","year":"2015","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.celrep.2020.108407_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2012.12.087","article-title":"Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study","volume":"163","author":"M\u00e5rild","year":"2013","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.celrep.2020.108407_bib35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ajh\/hpy083","article-title":"Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall","volume":"31","author":"Martinez-Quinones","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.celrep.2020.108407_bib36","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2353\/ajpath.2009.090059","article-title":"Interferon-gamma differentially affects Alzheimer\u2019s disease pathologies and induces neurogenesis in triple transgenic-AD mice","volume":"175","author":"Mastrangelo","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2020.108407_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ijc.2910490115","article-title":"Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells","volume":"49","author":"Matthys","year":"1991","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2020.108407_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2020.108407_bib39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2015.12.032","article-title":"Parsing the Interferon Transcriptional Network and Its Disease Associations","volume":"164","author":"Mostafavi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2020.108407_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.molmed.2018.02.001","article-title":"Therapeutic Perspectives for Interferons and Plasmacytoid Dendritic Cells in Rheumatoid Arthritis","volume":"24","author":"Nehmar","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib41","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3201\/eid1608.091931","article-title":"Pandemic (H1N1) 2009 virus and Down syndrome patients","volume":"16","author":"P\u00e9rez-Padilla","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2020.108407_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20131043","article-title":"Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons","volume":"211","author":"Pietras","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib43","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2020.108407_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdcr.2019.02.007","article-title":"Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata","volume":"5","author":"Rachubinski","year":"2019","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.celrep.2020.108407_bib45","first-page":"79","article-title":"Fatty Infiltration of the Liver in Patients with Mongolism and in Children with Hydrocephaly and Microcephaly","volume":"23","author":"Roosen-Runge","year":"1947","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2020.108407_bib46","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2020.108407_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.celrep.2020.108407_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11689-019-9306-9","article-title":"Health comorbidities and cognitive abilities across the lifespan in Down syndrome","volume":"12","author":"Startin","year":"2020","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.celrep.2020.108407_bib49","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2020.108407_bib50","doi-asserted-by":"crossref","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2020.108407_bib51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.neurobiolaging.2013.10.089","article-title":"Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer\u2019s disease","volume":"35","author":"Taylor","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2020.108407_bib52","first-page":"492","article-title":"Markers for predicting death as an outcome for mice used in infectious disease research","volume":"61","author":"Trammell","year":"2011","journal-title":"Comp. Med."},{"key":"10.1016\/j.celrep.2020.108407_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpeds.2017.05.077","article-title":"Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features","volume":"189","author":"Valentini","year":"2017","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.celrep.2020.108407_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.61867","article-title":"Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series","author":"Villani","year":"2020","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.celrep.2020.108407_bib55","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","article-title":"Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome","volume":"29","author":"Waugh","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2020.108407_bib56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2020.108407_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","article-title":"Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice","volume":"1366","author":"Yu","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.celrep.2020.108407_bib58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.celrep.2020.108407_bib59","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","article-title":"Liver-Mediated Adaptive Immune Tolerance","volume":"10","author":"Zheng","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124720313966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124720313966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:08:40Z","timestamp":1761908920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124720313966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2211124720313966"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2020.108407","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.07.024455","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2020.108407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"108407"}}